Clinical Trial Update: I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers [EARLY_Phase 1]

View source ↗

Summary

Phase 1 trial update for I2PETHV investigating Imidazoline2 binding site in healthy volunteers; results posted for an early phase study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Healthy Volunteers

Snippet

Sponsor: Imperial College London | Conditions: Healthy Volunteers, Alzheimer Disease | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-11-15